Intravenous Magnesium Sulphate in Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
Magnesium has a neuroprotective role so the investigators aim to evaluate the role of
intravenous magnesium sulphate in improving the clinical outcomes as assessed by the NIH
Stroke Scale (NIHSS) in patients with acute ischemic stroke.